1. Home
  2. TAL vs BLCO Comparison

TAL vs BLCO Comparison

Compare TAL & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TAL Education Group

TAL

TAL Education Group

N/A

Current Price

$11.02

Market Cap

6.4B

Sector

Real Estate

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$17.46

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TAL
BLCO
Founded
2003
1853
Country
China
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Ophthalmic Goods
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.0B
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
TAL
BLCO
Price
$11.02
$17.46
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$11.15
$18.55
AVG Volume (30 Days)
3.5M
438.6K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$34.12
$8.61
Revenue Next Year
$22.50
$5.52
P/E Ratio
$23.36
N/A
Revenue Growth
N/A
6.47
52 Week Low
$8.50
$10.45
52 Week High
$14.66
$18.92

Technical Indicators

Market Signals
Indicator
TAL
BLCO
Relative Strength Index (RSI) 49.44 48.74
Support Level $10.67 $16.35
Resistance Level $11.14 $17.66
Average True Range (ATR) 0.33 0.49
MACD 0.02 -0.12
Stochastic Oscillator 82.65 31.12

Price Performance

Historical Comparison
TAL
BLCO

About TAL TAL Education Group

TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions. Among those business lines, TAL focuses on enrichment learning and content solutions.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: